H.R. 8840

Fair Care Act of 2026

Sponsor: Bruce Westerman · 0 cosponsors

Follow this bill

Official summary

No official summary yet.

Text of the bill

Expand all

I Modernization of health savings accounts

A Modernization of health savings accounts and contributions

B Assistance to health savings accounts

II Improving Private Health Insurance

A Maintaining Protections for Patients with Preexisting Conditions

B Expanding Coverage Options

C Improving Commercial Health Insurance

III Competition, Transparency and Accountability

A Provider and Insurer Competition

B Price Transparency

C Prescription Drug Competition and Innovation

Sec. 355. Government Accountability Office study of rules

(a) In general. The Comptroller General of the United States shall conduct a study to determine, as of the date of the enactment of this Act—

(1) how many rules (as such term is defined in section 804 of title 5, United States Code) were in effect;

(2) how many major rules (as such term is defined in section 804 of title 5, United States Code) were in effect; and

(3) the total estimated economic cost imposed by all such rules.

(b) Report. Not later than 1 year after the date of the enactment of this Act, the Comptroller General of the United States shall submit a report to Congress that contains the findings of the study conducted under subsection (a).

D Prescription Drug and Pharmacy Benefit Manager Transparency

E Medicare and Medicaid Prescription Drug Reforms

F Medical Malpractice Reform

IV Medicare and Medicaid Reforms

A Medicaid Reforms

B Medicare Reforms

C Medicare Choice and Competition

D Telehealth Improvements and Expansion